NextFerm Technologies Ltd (TLV:NXFR.M)
Israel · Delayed Price · Currency is ILS · Price in ILA 8,268.00
-22.00 (-0.27%)
At close: Jun 18, 2026
NextFerm Technologies Revenue
In the year 2025, NextFerm Technologies had annual revenue of $147.00K USD, down -15.52%.
Revenue
$147.00K
Revenue Growth
-15.52%
P/S Ratio
59.61
Revenue / Employee
$13.36K
Employees
11
Market Cap
27.94M ILS
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 147.00K | -27.00K | -15.52% |
| Dec 31, 2024 | 174.00K | -109.00K | -38.52% |
| Dec 31, 2023 | 283.00K | 21.00K | 8.02% |
| Dec 31, 2022 | 262.00K | 20.00K | 8.26% |
| Dec 31, 2021 | 242.00K | 147.00K | 154.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Skyline Investments | 185.79M |
| Parkomat International | 71.17M |
| RoboGroup T.E.K. | 27.38M |
| Identi Healthcare | 10.93M |
| NRGene Technologies | 10.11M |
| Tomer Food Combination | 4.64M |
| Y.B Urban Renewal - Residential Development | 538.00K |
| BioLight Life Sciences | 21.00K |